RecruitingNCT06482073

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Sponsor

Mayo Clinic

Enrollment

40 participants

Start Date

Jun 24, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Carcinoma Metastatic Malignant Neoplasm in the Lung

Summary

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

Subject age 18 years and older
Subject is scheduled/was scheduled for a bronchoscopy as part of standard of care
Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
Ability to provide blood or saliva sample
Ability to provide archived tissue
Subject is able to understand and adhere to study requirements and able to provide informed consent

Exclusion Criteria5

Individuals who have situations that would limit compliance with the study requirements
Institutionalized (i.e. federal medical prison)
Pregnant
Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment
Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment